Request A Test
My Account

National Leader in Affordable Direct to Consumer Lab Testing

1-888-732-2348 1-866-383-2766 español View Your Order

Request A Test will be closed Nov. 23rd & Nov. 24th for Thanksgiving. We will observe normal business hours for the rest of the week.

Find a Test

Screening Recommendations and Considerations Referenced in Treatment Guidelines and Original Sources

November 1, 2017

 Chlamydia

Women

  • Sexually active women under 25 years of age
  • Sexually active women aged 25 years and older if at increased risk
  • Retest approximately 3 months after treatment

Pregnant Women

  • All pregnant women under 25 years of age
  • Pregnant women, aged 25 and older if at increased risk
  • Retest during the 3rd trimester for women under 25 years of age or at risk
  • Pregnant women with chlamydial infection should have a test-of-cure 3-4 weeks after trestment an be retested within 3 months

Men

  • Consider screening young men in high prevalence clinical settings or in populations with high burden of infection

Men Who have Sex With Men (MSM)

  • At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use
  • Every 3 to 6 months if at increased risk

Persons with HIV

  • For sexually active individuals, screen at first HIV evaluation, and at least annually thereafter
  • More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology

Gonorrhea

Women

  • Sexually active women under 25 years of age
  • Sexually active women age 25 years and older if at increased risk
  • Retest 3 months after treatment

Pregnant Women

  • All pregnant women under 25 years of age and older women if at increased risk
  • Retest 3 months after treatment

Men Who have Sex With Men (MSM)

  • At least annually for sexually active MSM at sites of contact (urethra, rectum) regardless of condom use
  • Every 3 to 6 months if at increased risk

Persons with HIV

  • For sexually active individuals, Screen at first HIV evaluation, and at least annually thereafter
  • More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology

Syphilis

Pregnant Women

  • All pregnant women at the first prenatal visit
  • Retest early in the third trimester and at delivery if at high risk

Men Who have Sex With Men (MSM)

  • At least annually for sexually active MSM
  • Every 3 to 6 months if at increased risk

Persons with HIV

  • For sexually active individuals, Screen at first HIV evaluation, and at least annually thereafter
  • More frequent screening for might be appropriate depending on individual risk behaviors and the local epidemiology

Trichomonas

Women

  • Consider for women receiving care in high-prevalence settings (e.g., STD clinics and correctional facilities) and for women at high risk for infection (e.g., women with multiple sex partners, exchanging sex for payment, illicit drug use, and a history of STD)

Persons with HIV

  • Recommended for sexually active women at entry to care and at least annually thereafter

Herpes

Women

  • Type-specific HSV serologic testing should be considered for women presenting for an STD evaluation (especially for women with multiple sex partners)

Pregnant Women

  • Evidence does not support routine HSV-2 serologic screening among asymptomatic pregnant women. However, type-specific serologic tests might be useful for identifying pregnant women at risk for HSV infection and guiding counseling regarding the risk for acquiring genital herpes during pregnancy

Men

  • Type-specific HSV serologic testing should be considered for men presenting for an STD evaluation (especially for men with multiple sex partners)

Men Who have Sex With Men (MSM)

  • Type-specific serologic tests can be considered if infection status is unknown in MSM with previously undiagnosed genital tract infection

Persons with HIV

  • Type-specific HSV serologic testing should be considered for persons presenting for an STD evaluation (especially for those persons with multiple sex partners), persons with HIV infection, and MSM at increased risk for HIV acquisition

HIV

Women

  • All women aged 13-64 years (opt-out)
  • All women who seek evaluation and treatment for STDs

Pregnant Women

  • All pregnant women should be screened at first prenatal visit (opt-out)
  • Retest in the third trimester if at high risk

Men

  • All men aged 13-64 (opt-out)
  • All men who seek evaluation and treatment for STDs

Men Who have Sex With Men (MSM)

  • At least annually for sexually active MSM if HIV status is unknown or negative and the patient himself or his sex partner(s) have had more than one sex partner since most recent HIV test

Cervical Cancer

Women

  • Women 21-29 years of age every 3 years with cytology
  • Women 30-65 years of age every 3 years with cytology, or every 5 years with a combination of cytology and HPV testing

Pregnant Women

  • Pregnant women should be screened at same intervals as nonpregnant women

Persons with HIV

  • Women should be screened within 1 year of sexual activity or initial HIV diagnosis using
    conventional or liquid-based cytology; testing should be repeated 6 months later

Hepatitis B Screening

Women

  • Women at increased risk

Pregnant Women

  • Test for HBsAg at first prenatal visit of each pregnancy regardless of prior  testing; retest at delivery if at high risk

Men

  • Men at increased risk

Men Who have Sex With Men (MSM)

  • All MSM should be tested for HBsAg

Persons with HIV

  • Test for HBsAg and anti-HBc and/or anti-HBs

Hepatitis C Screening

Women

  • Women born between 1945-1965
  • Other women If risk factors are present

Pregnant Women

  • Pregnant women born between 1945-1965
  • Other pregnant women if risk factors are present

Men

  • Men born between 1945-1965
  • Other men If risk factors are present

Men Who have Sex With Men (MSM)

  • MSM born between 1945-1965
  • Other MSM if risk factors are present
  • Annual HCV testing in MSM with HIV infection

Persons with HIV

  • Serologic testing at initial evaluation
  • Annual HCV testing in MSM with HIV infection

Source: https://www.cdc.gov/std/tg2015/screening-recommendations.htm

Location Search

3 easy steps STD Testing Step 1 STD Testing Step 2 STD Testing Step 3
STD Test Specials

Test Specials

 

 For the

month of

November

 

 Take 10% off all STD Testing.

Use promo code STD10.

 

Cannot be applied to industry discounted prices, previous orders or tests not listed on our website. One coupon code per order. Coupon code expires on November 30th at Midnight EST.